v3.25.4
Investments - Summary of Statements of operations (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Shedule Of Equity Method Investment Summarized Statement Of Operations [Line Items]    
Revenue $ 4,089 $ 308
Net loss (660,147) (150,049)
GABA Therapeutics Inc [Member]    
Shedule Of Equity Method Investment Summarized Statement Of Operations [Line Items]    
Loss from continuing operations (724) (3,227)
Net loss $ (724) $ (3,227)